Last Updated: May 11, 2026

CLINICAL TRIALS PROFILE FOR MPI DTPA KIT - CHELATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MPI DTPA KIT - CHELATE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00440583 ↗	The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP	Completed	Bayer	Phase 2	2006-09-01	The purpose of this study is to determine the effective of Yt90-Zevalin therapy in patients with diffuse large B-cell lymphoma that have achieved at least an unconfirmed partial remission after 6 cycles of CHOP therapy.
NCT00440583 ↗	The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP	Completed	Mahidol University	Phase 2	2006-09-01	The purpose of this study is to determine the effective of Yt90-Zevalin therapy in patients with diffuse large B-cell lymphoma that have achieved at least an unconfirmed partial remission after 6 cycles of CHOP therapy.
NCT00461149 ↗	Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly	Completed	Federico II University	Phase 4	1995-01-01	Epidemiological data indicate that patients with active acromegaly have reduced life expectancy because of cardiovascular (60%) and respiratory diseases (25%) mainly (1-10). A post-treatment GH value
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MPI DTPA KIT - CHELATE

Condition Name

Chart
Table

Condition Name for MPI DTPA KIT - CHELATE
Intervention	Trials
Iron Deficiency Anemia	3
COVID19	3
COVID-19	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MPI DTPA KIT - CHELATE
Intervention	Trials
COVID-19	5
Anemia, Iron-Deficiency	5
Anemia	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MPI DTPA KIT - CHELATE

Trials by Country

Map
Table

Trials by Country for MPI DTPA KIT - CHELATE
Location	Trials
United States	30
Japan	14
Italy	9
Germany	7
China	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MPI DTPA KIT - CHELATE
Location	Trials
Ohio	3
Missouri	3
California	3
Maryland	2
South Carolina	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MPI DTPA KIT - CHELATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MPI DTPA KIT - CHELATE
Clinical Trial Phase	Trials
PHASE1	1
Phase 4	7
Phase 3	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MPI DTPA KIT - CHELATE
Clinical Trial Phase	Trials
Completed	17
Unknown status	5
Not yet recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MPI DTPA KIT - CHELATE

Sponsor Name

Chart
Table

Sponsor Name for MPI DTPA KIT - CHELATE
Sponsor	Trials
National Cancer Institute (NCI)	2
Bayer	2
Replicor Inc.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MPI DTPA KIT - CHELATE
Sponsor	Trials
Other	28
Industry	15
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.